Through AMPK activation, metformin increases the expression of ATP-binding cassette transporter A1 (ABCA1), a key transporter involved in cholesterol efflux and apolipoprotein E (ApoE) function, which is critically implicated in AD progression [195]. Here, APOE is linked to Alzheimer disease.